Answers are grounded in this paper and cite their sources.
Quantitative trait loci (QTL) studies have been pivotal in mapping the genetic regulation of molecular traits but have been primarily conducted in European populations, limiting insights into diverse ethnic groups. To close this knowledge gap, we conduct a large-scale multi-omics QTL analysis using blood samples from 3,102 Chinese individuals, systematically characterizing the regulatory effects of genetic variants on DNA methylation, plasma levels of 365 inflammation-related proteins, and metabolites. Our study identifies 209 protein QTLs (pQTLs) for 155 proteins and 587 metabolite QTLs (metabQTLs) for 369 metabolites. By integrating these findings with cis-methylation QTL (meQTL) from our previous work, we define the shared genetic architecture across molecular layers. Colocalization analyses reveal 3,665 pairs of shared causal variants across traits, including loci such as LHPP, with mediation evidence supporting regulatory cascades linking DNA methylation, proteins, and metabolites. To link these molecular findings to health outcomes, we perform Mendelian randomization (MR) analyses, identifying 497 potential causal relationships between molecular traits and diseases, including FCRL3 for Graves’ disease and deoxycholic acid 3-glucuronide for colorectal cancer. Collectively, we present a systematic genomic atlas of meQTLs, pQTLs, and metabQTLs specific to East Asian populations, providing critical insight into shared regulatory networks and candidate causal variants across molecular and disease phenotypes. The authors establish a multi-omics quantitative trait locus (QTL) atlas in a Chinese population by characterizing protein and metabolite QTLs and integrating DNA methylation QTLs, revealing shared genetic regulation across molecular layers and links to human diseases.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: